- 18 February 2025
- journal article
- review article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 218-223
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Impact of elexacaftor/tezacaftor/ivacaftor CFTR modulator therapy on rates of endoscopic sinus surgery in cystic fibrosisInternational Forum of Allergy & Rhinology, 2024
- Mental health, sleep, and respiratory health after initiating elexacaftor/tezacaftor/ivacaftor treatment in children with cystic fibrosisPediatric Pulmonology, 2024
- International disparities in diagnosis and treatment access for cystic fibrosisPediatric Pulmonology, 2024
- Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyClinical Pharmacokinetics, 2024
- Time to be blunt: Substance use in cystic fibrosisPediatric Pulmonology, 2024
- Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort StudyJournal of Cystic Fibrosis, 2023
- Use of cystic fibrosis inhaled medication before and after elexacaftor/tezacaftor/ivacaftor initiationJournal of Cystic Fibrosis, 2023
- Changes in liver biochemistry and tacrolimus levels following the introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver transplantJournal of Cystic Fibrosis, 2023
- Eradication of Mycobacterium abscessus infection in cystic fibrosis with initiation of Elexacaftor/Tezacaftor/IvacaftorJournal of Cystic Fibrosis, 2023
- Impact of chronic medication de-escalation in patients with cystic fibrosis taking elexacaftor, tezacaftor, ivacaftor: A retrospective reviewJournal of Cystic Fibrosis, 2023